Capital International Investors 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-05 2:04 pm Sale | 2026-01-30 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 1,186,794 1.200% | -5,147,348 (-81.26%) | Filing |
| 2025-05-13 5:53 pm Sale | 2025-03-31 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 6,334,142 7.400% | -1,889,852 (-22.98%) | Filing |
| 2024-04-10 11:58 am Purchase | 2024-04-10 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 8,223,994 10.200% | 1,803,258 (+28.08%) | Filing |
| 2024-02-09 6:03 pm Purchase | 2024-02-07 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 6,420,736 8.100% | 860,244 (+15.47%) | Filing |
| 2023-02-13 3:54 pm Purchase | 2023-02-14 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 5,560,492 7.100% | 1,854,488 (+50.04%) | Filing |
| 2022-02-11 11:19 am Sale | 2022-02-14 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 3,706,004 4.800% | -558,998 (-13.11%) | Filing |
| 2021-08-10 12:28 pm Sale | 2021-08-10 | 13G | CRISPR Therapeutics AG CRSP | Capital International Investors | 4,265,002 5.600% | -3,361,353 (-44.08%) | Filing |